Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123623372 | 12362337 | 2 | F | 20080909 | 20160831 | 20160512 | 20160907 | EXP | US-DSJP-DSU-2016-107186 | DAIICHI | 0.00 | Y | 0.00000 | 20160907 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123623372 | 12362337 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 20 MG, QD | Y | 21286 | 20 | MG | TABLET | QD | ||||||
| 123623372 | 12362337 | 2 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/12.5 MG, UNK | U | 0 | 1 | DF | FILM-COATED TABLET | |||||||
| 123623372 | 12362337 | 3 | C | VISTARIL | HYDROXYZINE PAMOATE | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
| 123623372 | 12362337 | 4 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 20 MEQ, BID | 0 | 20 | MEQ | BID | ||||||||
| 123623372 | 12362337 | 5 | C | TRANDATE | LABETALOL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 123623372 | 12362337 | 6 | C | PRIMROSE | 2 | 500 MG, UNK | 0 | 500 | MG | ||||||||||
| 123623372 | 12362337 | 7 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | UNK | 0 | |||||||||||
| 123623372 | 12362337 | 8 | C | MULTIVITAMIN /00097801/ | VITAMINS | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123623372 | 12362337 | 1 | Product used for unknown indication |
| 123623372 | 12362337 | 2 | Hypertension |
| 123623372 | 12362337 | 3 | Product used for unknown indication |
| 123623372 | 12362337 | 4 | Product used for unknown indication |
| 123623372 | 12362337 | 5 | Product used for unknown indication |
| 123623372 | 12362337 | 6 | Product used for unknown indication |
| 123623372 | 12362337 | 7 | Product used for unknown indication |
| 123623372 | 12362337 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123623372 | 12362337 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123623372 | 12362337 | Acute kidney injury | |
| 123623372 | 12362337 | Cholelithiasis | |
| 123623372 | 12362337 | Crohn's disease | |
| 123623372 | 12362337 | Malabsorption |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123623372 | 12362337 | 2 | 20080331 | 2012 | 0 |